Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Collaborative Health Research Projects (NSERC partnered)

University of British Columbia

$323,547.00

Novel antimircrobial and biofilm resistant coatings for urological and blood storage devices

EF 2011-12

Résumé
"This research addresses serious challenge in hospital acquired infections: the prevention of bacterial infections associated with urological devices and bacterial growth in blood products for transfusion. Urinary catheters is one of most frequently used medical device in hospitals in North America and catheter associated infections account for a major share of hospital acquired infectious. In addition to increased mortality, these complications add millions of extra health care costs. Currently, antibiotics are our only method of attempting to deal with these infections, but do not work well due to intrinsic multidrug resistance of biofilms on catheter surface. The transfusion of bacterial contaminated blood products is another longstanding serious complication. In North America, approximately 15 million units of packed red blood cells and 4.5 million units of platelets are transfused every year. The incidence of bacterial contamination associated with the storage is as high as 1 per every 2000 units. This represents a huge cost to the health care system. Our collaborative project seeks novel solutions to these issues by developing new generation antibacterial surface coating on urinary catheters and blood bags without employing classical antibiotics. Since catheters, and blood bags are made of common plastic materials, similar technology can be applied to each devices. The project is based on the latest breakthroughs at UBC on screening and optimization of short broad spectrum cationic antimicrobial peptides (AMPs) and their application to implant surfaces. The objectives of the project will be achieved by i development of hydrophilic polymer brush based AMP coating for catheters, and blood bags and the optimization of their antimicrobial/anti-biofilm activity and biocompatibility, ii) elucidation of the mechanism of action of surface immobilized AMPs, iii) in vitro and in vivo evaluations of AMP coated blood bags and catheters in an animal infection model. The project will establish a strong collaboration among, science, engineering and medicine, and provide unique HQP training opportunities. The novel anti-infection coatings will also provide a general method for preventing bacterial infections associated with other medical devices."
Programme
Collaborative Health Research Projects (NSERC partnered)
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
249606
Name
Kizhakkedathu Jayachandran N
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Natural Sciences and Engineering Research Council of Canada (NSERC)
Prcname2
Collaborative Health Research Projects - NSERC Partnered
Projecttitle
Novel antimircrobial and biofilm resistant coatings for urological and blood storage devices
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$323,547
Cihrequipment2
$0
Programname2
Collaborative Health Research Projects (NSERC partnered)
Keyworddelim
Antibacterial Surfaces; Antibiotics Resistence; Antimicrobial Peptides; Bacterial Contamination; Biocompatible Polymer Coatings; Biofilm Resistence; Blood Storage Devices; Implant Associated Infection; Polymeric Biomaterials; Urological Catheters
Abstract
"This research addresses serious challenge in hospital acquired infections: the prevention of bacterial infections associated with urological devices and bacterial growth in blood products for transfusion. Urinary catheters is one of most frequently used medical device in hospitals in North America and catheter associated infections account for a major share of hospital acquired infectious. In addition to increased mortality, these complications add millions of extra health care costs. Currently, antibiotics are our only method of attempting to deal with these infections, but do not work well due to intrinsic multidrug resistance of biofilms on catheter surface. The transfusion of bacterial contaminated blood products is another longstanding serious complication. In North America, approximately 15 million units of packed red blood cells and 4.5 million units of platelets are transfused every year. The incidence of bacterial contamination associated with the storage is as high as 1 per every 2000 units. This represents a huge cost to the health care system. Our collaborative project seeks novel solutions to these issues by developing new generation antibacterial surface coating on urinary catheters and blood bags without employing classical antibiotics. Since catheters, and blood bags are made of common plastic materials, similar technology can be applied to each devices. The project is based on the latest breakthroughs at UBC on screening and optimization of short broad spectrum cationic antimicrobial peptides (AMPs) and their application to implant surfaces. The objectives of the project will be achieved by i development of hydrophilic polymer brush based AMP coating for catheters, and blood bags and the optimization of their antimicrobial/anti-biofilm activity and biocompatibility, ii) elucidation of the mechanism of action of surface immobilized AMPs, iii) in vitro and in vivo evaluations of AMP coated blood bags and catheters in an animal infection model. The project will establish a strong collaboration among, science, engineering and medicine, and provide unique HQP training opportunities. The novel anti-infection coatings will also provide a general method for preventing bacterial infections associated with other medical devices."
Competitiondate
201110
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Kizhakkedathu, Jayachandran N
Approvedterm
3 ans 0 mois
Cihrcontribution2
Knowledge Translation Branch~ $323,547~ $0~